Updated
Anixa BiosciencesANIX · Healthcare
$3.18+4.95%
Market cap$110M
IndustryBiotechnology
Anixa Biosciences (ANIX) Superinvestor holders
2 of the superinvestors we track hold Anixa Biosciences (ANIX) in their latest 13F filings, $1M in total.
Summary
The largest holder is Paul Marshall (Marshall Wace), with $919,332, 0.0% of the portfolio.
In their latest quarter: 1 added, 1 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Paul Marshall Marshall Wace |
Added | 328,332 | $919,332 | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 59,373 | $166,244 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 2 |
| Q1 2026 | 5 |
| Q4 2025 | 5 |
| Q3 2025 | 3 |
| Q2 2025 | 2 |
| Q1 2025 | 1 |
| Q4 2024 | 1 |
| Q3 2024 | 2 |
Questions about Anixa Biosciences
Which superinvestors own Anixa Biosciences?
2 of the superinvestors we track hold Anixa Biosciences (ANIX) in their latest 13F filings, $1M in total. Paul Marshall, Jim Simons.
Who is the largest superinvestor holder of ANIX?
The largest holder is Paul Marshall (Marshall Wace), with $919,332, 0.0% of the portfolio.
From Anixa Biosciences's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.